Huntsman Corporation
NYSE:HUNChemicals
-$0.46 today
- Market cap
- $1.58B
- Beta
- 0.66
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$1.87
- Dividend yield
- 4.18%
Volume 3.62M
Average 5.21M
HUN EBITDA Margin
EBITDA as a percentage of revenue.
Huntsman CorporationNYSE: HUN
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin narrows to 4.6%
EBITDA Margin was 4.6% in Q1 FY2026, down 3.6 pp from a year earlier. On a trailing-twelve-month basis it was 2.2%, down 4.4 pp year over year. Over 3 fiscal years it narrowed by 9.9 pp.
Context
- EBITDA Margin widened in 0 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 10 analysts of 4.8% for the fiscal year ending Dec 2026, up from 3.1% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- 4.6%+3.2 pp QoQ
- Last fiscal yearDec 2025
- 3.1%-2.4 pp YoY
- LTMMar 2026
- 2.2%-4.4 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -3.6 pp | +10.2 pp | +13.7 pp |
| 1 year | -2.4 pp | +1.7 pp | +4.1 pp |
| 3 years | -9.9 pp | +3.1 pp | +13.0 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 3.1%
- Year-over-year change
- -2.4pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.1% | -2.4pp |
| FY2024 | 2024-12-31 | 5.5% | -1.8pp |
| FY2023 | 2023-12-31 | 7.2% | -5.7pp |
| FY2022 | 2022-12-31 | 13.0% | -7.8pp |
| FY2021 | 2021-12-31 | 20.7% | — |
EBITDA Margin vs competitors
How HUN compares with its peers on the latest reported figures
- HUN's LTM Mar 2026 EBITDA Margin of 2.2% is the 5th highest of the 8 companies compared; the peer median is 10.4%.
- Its year-over-year change of -4.4 pp is the 5th highest of 8, against a peer median of +3.4 pp.
- Over three fiscal years its change of -9.9 pp compares with a peer median of -1.3 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 29.7% | -18.0 pp | -1.3 pp | |
| LTM Mar 2026 | 27.7% | +11.4 pp | +2.7 pp | |
| LTM Jun 2026 | 11.4% | +3.4 pp | +6.1 pp | |
| LTM Mar 2026 | 10.4% | +10.7 pp | -7.5 pp | |
| LTM Mar 2026 | 2.2% | -4.4 pp | -9.9 pp | |
| LTM Jun 2026 | -2.9% | -8.3 pp | -11.8 pp | |
| LTM Mar 2026 | -633.6% | +115.1 pp | — | |
| LTM Jun 2025 | -8466.9% | -5887.9 pp | — | |
| FY2024 | — | — | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding HUN) | 10.4% | +3.4 pp | -1.3 pp | |
Competitors are the stored peer set for HUN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 7.67B | 8.02B | 6.11B | 6.04B | 5.68B |
| Cost of Revenue | 6.09B | 6.48B | 5.21B | 5.17B | 4.93B |
| Gross Profit | 1.58B | 1.55B | 906M | 866M | 751M |
| Gross Margin | 20.7% | 19.3% | 14.8% | 14.3% | 13.2% |
| Research & Development | 135M | 125M | 115M | 121M | 120M |
| Selling, General & Admin | 739M | 711M | 689M | 671M | 670M |
| Operating Expenses | 853M | 874M | 822M | 891M | 790M |
| Depreciation & Amortization | 278M | 281M | 278M | 289M | 287M |
| EBITDA | 1.59B | 1.04B | 442M | 329M | 174M |
| EBITDA Margin | 20.7% | 13.0% | 7.2% | 5.5% | 3.1% |
| Operating Income | 731M | 672M | 84M | (25M) | (39M) |
| Operating Margin | 9.5% | 8.4% | 1.4% | -0.4% | -0.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 67M | 62M | 65M | 79M | 79M |
| Other Income / Expenses | 515M | 25M | 15M | (14M) | (153M) |
| Income Before Tax | 1.25B | 697M | 99M | (39M) | (192M) |
| Pre-Tax Margin | 16.2% | 8.7% | 1.6% | -0.6% | -3.4% |
| Income Tax Expense | 191M | 186M | 64M | 61M | 26M |
| Net Income | 1.05B | 460M | 101M | (189M) | (275M) |
| Net Margin | 13.6% | 5.7% | 1.7% | -3.1% | -4.8% |
| EPS (Basic) | 4.77 | 2.29 | 0.57 | (1.10) | (1.59) |
| EPS (Diluted) | 4.72 | 2.27 | 0.57 | (1.10) | (1.59) |
| Weighted Avg Shares | 219.2M | 201M | 177.4M | 172.1M | 172.6M |
| Weighted Avg Shares (Diluted) | 221.4M | 203M | 177.4M | 172.1M | 172.6M |
Huntsman Corporation
NYSE:HUN
Intrinsic Alpha fair value
Locked
Current Price
$9.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.